Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
H285A
-
display a low level of supercoil relaxation. Slow the rate of cleavage by a factor of 60 compared to the wild-type
R135A
-
form no detectable protein-DNA adduct during a 24 h incubation with the suicide substrate. The failure of this protein to relax supercoiled DNA is probably attributable to its inability to perform transesterification chemistry
R241A
-
form no detectable protein-DNA adduct during a 24 h incubation with the suicide substrate. The failure of this protein to relax supercoiled DNA is probably attributable to its inability to perform transesterification chemistry
Y294A
-
form no detectable protein-DNA adduct during a 24 h incubation with the suicide substrate. The failure of this protein to relax supercoiled DNA is probably attributable to its inability to perform transesterification chemistry
V617G
the mutant is resistant against topotecan
D113N
-
EcTOP, site-directed mutagenesis
D117N
-
site-directed mutagenesis, induction of mutant YpTOP1-D117N topoisomerase by arabinose is similar in the absence or presence of trimethoprim
G116S
-
EcTOP 67 kDa N-terminal fragment, site-directed mutagenesis
G194A
-
40fold reduction in relaxation activity when compared to wild-type enzyme, DNA cleavage activity is 100fold lower than that of the wild-type enzyme
G194R
-
no detectable relaxation activity and DNA cleavage
H365A
-
whereas wild type enzyme shows pH-dependent cleavage of oligonucleotides, cleavage by the mutant enzyme is pH-independent. Cleaves DNA with a slower rate than the wild-type enzyme, but can cleave more substrate overall, mutant enzyme has a lower DNA binding affinity than the wild-type enzyme, mutant shows a shift in maximal relaxation to above pH 8.5, mutant enzyme is less able than the wild type enzyme to relax negatively supercoiled DNA
H365D |
-
mutant shows a shift in maximal relaxation to above pH 8.5, mutant enzyme is less able than the wild type enzyme to relax negatively supercoiled DNA
H365E |
-
mutant shows a shift in maximal relaxation to above pH 8.5, mutant enzyme is less able than the wild type enzyme to relax negatively supercoiled DNA
H365N
-
mutant shows a shift in maximal relaxation to above pH 8.5, mutant enzyme is less able than the wild type enzyme to relax negatively supercoiled DNA
H365Q
-
whereas wild type enzyme shows pH-dependent cleavage of oligonucleotides, cleavage by the mutant enzyme is pH-independent. Cleaves DNA with rates similar to the wild-type enzyme, mutant shows a shift in maximal relaxation to above pH 8.5, mutant enzyme is less able than the wild type enzyme to relax negatively supercoiled DNA
H365R |
-
mutant shows a shift in maximal relaxation to above pH 8.5, mutant enzyme is less able than the wild type enzyme to relax negatively supercoiled DNA
K13A
-
Investigation of the potential catalytic role of the serine and lysine residue conserved in the active site region of bacterial topoisomerase I Ser10 and Lys13 of Escherichia coli DNA topoisomerase I are mutated to alanines. 50-to 100fold reduction in relaxation activity, not affected in non-covalent DNA binding, mutations at Ser10 and Lys13 highly reduce the ability of topoisomerase I to support growth of the Escherichia coli cells, as expected from the loss of the relaxation activity. Ala13 is unable to make interactions with the acidic residues of the active site. Side chains of Ser10 and Lys13 are required for DNA cleavage activity, rates of cleavage are too low to be analyzed
K13R
-
Arg13 residue is a larger residue than lysine, and is unable to fit in the space assigned to Lys13. Reduced DNA binding affinity, possibly changing Ser10 to a threonine residue, and changing Lys13 to arginine allow retention of activity, relaxation activity assays show that introduction of a different side chain with similar functionality but different steric properties at these two positions result in even lower relaxation activitymutations at Ser10 and Lys13 highly reduce the ability of topoisomerase I to support growth of the Escherichia coli cells, as expected from the loss of the relaxation activity. Do not have severe changes in protein folding. Side chains of Ser10 and Lys13 are required for DNA cleavage activity, rates of cleavage are too low to be analyzed
M320R
site-directed mutagenesis
R169
-
site-directed mutagenesis, the mutant shows reduced DNA cleavage and relaxation activity compared to the wild-type enzyme, the mutation to alanine changesd the selectivity of the enzyme for the base at the -4 position from a cytosine to an adenine
R173A
-
site-directed mutagenesis, the mutant displays similar sequence selectivity as the wild-type enzyme, but weaker cleavage and relaxation activity
R321F
-
site-directed mutagenesis, constants of oligonucleotide binding compared to the wild-type enzyme, the mutant shows reduced DNA cleavage and requirement for Mg2+
R321K
-
site-directed mutagenesis, constants of oligonucleotide binding compared to the wild-type enzyme, the mutant shows reduced DNA cleavage and requirement for Mg2+
R321L
-
site-directed mutagenesis, constants of oligonucleotide binding compared to the wild-type enzyme, the mutant shows reduced DNA cleavage and requirement for Mg2+
S10A
-
Investigation of the potential catalytic role of the serine and lysine residue conserved in the active site region of bacterial topoisomerase I Ser10 and Lys13 of Escherichia coli DNA topoisomerase I are mutated to alanines. 5-to 10fold reduction in relaxation activity, not affected in non-covalent DNA binding, mutations at Ser10 and Lys13 highly reduce the ability of topoisomerase I to support growth of the Escherichia coli cells, as expected from the loss of the relaxation activity. Ala10 is unable to form a hydrogen bond with phosphate 8. Side chains of Ser10 and Lys13 are required for DNA cleavage activity, yield of the cleaved complex observed is 30fold lower than the wild-type enzyme at each enzyme: substrate ratio even after 60 min of incubation
S10T
-
Reduced DNA binding affinity, possibly changing Ser10 to a threonine residue, and changing Lys13 to arginine allow retention of activity, relaxation activity assays show that introduction of a different side chain with similar functionality but different steric properties at these two positions result in even lower relaxation activitymutations at Ser10 and Lys13 highly reduce the ability of topoisomerase I to support growth of the Escherichia coli cells, as expected from the loss of the relaxation activity. Thr10 forms a hydrogen bond with phosphate 8. Do not have severe changes in protein folding. Side chains of Ser10 and Lys13 are required for DNA cleavage activity, rates of cleavage are too low to be analyzed
Y177A
-
site-directed mutagenesis, inactive mutant
Y177S
-
site-directed mutagenesis, inactive mutant
Y319F
-
site-directed mutagenesis, constants of oligonucleotide binding compared to the wild-type enzyme
D117N
-
site-directed mutagenesis, induction of mutant YpTOP1-D117N topoisomerase by arabinose is similar in the absence or presence of trimethoprim
-
A653P
-
known to be CPT resistant
Cropo4
-
chimeric enzyme, human topo I having residues 631-717 replaced by residues 314-317 of Cre
Cropo6
-
chimeric enzyme, human topo I having residues 631-717 replaced by residues 312-317 of Cre
Cropo8
-
chimeric enzyme, human topo I having residues 631-717 replaced by residues 312-319 of Cre
DELTA1-202
-
mutant enzyme is impaired in blunt end ligation but remains sensitive towards camptothecin in relaxation
DELTA191-206
-
mutant is distinguished from wild-type enzyme by a decreased relaxation rate at distributive and an increased rate under processive conditions. Mutant is strongly impaired in blunt end ligation and insensitive towards camptothecin in relaxation
E418K
-
the active site tyrosine. The Glu418Lys mutant is active and partially resistant to CPT in yeast cells expressed in yeast cells, display a camptothecin resistance that slowly decreases as a function of time
E710G
-
site-directed mutagenesis, the mutation is not detectable in tissue samples from colorectal cancer patients
F361S
camptothecin-resistant enzyme form
F617N
site-directed mutagenesis
G365C
-
camptothecin-resistant Top1(G365C) mutant
G622A
site-directed mutagenesis
G717D
-
the mutant enzyme is no more sensitive to camptothecin than the wild type enzyme
hTopoI (deltaNL)
-
hTopoI deletion mutant. Considering the domain organization, hTopoI distinguishes itself from both Vaccinia virus TopoI and the tyrosine recombinases, by having rather extensive N-terminal and linker domains. Investigation of the resolution activity of hTopoI deleted in either one or both of these domains. Two hTopoI variants, hTopoI(deltaN) lacking aa 1-202, and hTopoI(deltaNL) lacking aa 1-202 and 660-688. Deleting the N-terminal and linker domains of hTopoI in order to mimic the domain organization of Vaccinia virus TopoI and the tyrosine recombinases inhibited resolution of the Holliday junction substrate. hTopoI(deltaNL) forms dimers
hTopoI(deltaN)
-
hTopoI deletion mutant. Considering the domain organization, hTopoI distinguishes itself from both Vaccinia virus TopoI and the tyrosine recombinases, by having rather extensive N-terminal and linker domains. Investigation of the resolution activity of hTopoI deleted in either one or both of these domains. Two hTopoI variants, hTopoI(deltaN) lacking aa 1-202, and hTopoI(deltaNL) lacking aa 1-202 and 660-688. Deleting the N-terminal and linker domains of hTopoI in order to mimic the domain organization of Vaccinia virus TopoI and the tyrosine recombinases inhibited resolution of the Holliday junction substrate. hTopoI(deltaNL) forms dimers
I623V
site-directed mutagenesis
K532R
cleavage and religation activity of the mutant enzyme are reduced, cleavage is reduced to a greater extent than religation
K550Q
site-directed mutagenesis
K605Q
site-directed mutagenesis
K616M
site-directed mutagenesis
K616Q
site-directed mutagenesis
K616R
site-directed mutagenesis
K681A
-
site-directed mutagenesis, the mutation of Lys681, located on the tip of the linker domain, dramatically reduces the religation rate, the equilibrium of the mutant is shifted toward cleavage when compared to the wild-type enzyme. Mutation of residue 681 from lysine to alanine does not cause alterations in the linker domain secondary structure, and the main chain conformation of the mutated residue does not significantly change in relation with the neighbor residues, when compared to the wild-type protein
L603V
site-directed mutagenesis
L617I
-
site-directed mutagenesis, the mutation is not detectable in tissue samples from colorectal cancer patients
M621I
site-directed mutagenesis
M621S
site-directed mutagenesis
N618S
site-directed mutagenesis
N722S
camptothecin-resistant enzyme form, mutation leads to elimination of a water-mediated contact between the enzyme and topotecan
Q613R
site-directed mutagenesis
R364K/G717R
-
the mutations lead to resistance towards inhibitors SN-38 and NSC 743400
R621H
-
site-directed mutagenesis, the mutation is not detectable in tissue samples from colorectal cancer patients
S10A/S112A/S394A
-
triple mutant 3A
S10A/S21A/S112A/S394A
-
quadruple phosphomutant 4A
S21A
-
site-directed mutagenesis
T729A
-
mutations that confer camptothecin resistance, but do not interact directly with the drug or the DNA, oligonucleotide-directed mutagenesis
T729E
-
camptothecin resistance, remarkable defect in DNA binding, oligonucleotide-directed mutagenesis
W203A/W205A/W206A
lacking processivity, exhibits resistance to camptothecin and is inactivated by urea. Indicates that the tryptophan anchor stabilizes the N-terminus of the functional domain and revents the loss of Top1 structure and function
W205G
-
mutant is distinguished from wild-type enzyme by a decreased relaxation rate at distributive and an increased rate under processive conditions. Mutant is strongly impaired in blunt end ligation and insensitive towards camptothecin in relaxation
Y337F
-
mutant enzyme is still able to bind single-stranded DNA but is unable to cleave the DNA substrate because of the absence of the active Tyr337
Y552N
site-directed mutagenesis
Y612N
site-directed mutagenesis
Y727F
catalytically inactive
D325E
-
substantial level of resistance to camptothecin, 50% inhibition at 0.01 mM
delta 175-262
-
N-terminal truncation performed on LdTop1S subunits
delta 180-262
-
N-terminal truncation performed on LdTop1S subunits
delta 182-262
-
N-terminal truncation performed on LdTop1S subunits
delta 200-262
-
N-terminal truncation performed on LdTop1S subunits
delta 210-262
-
N-terminal truncation performed on LdTop1S subunits
delta 39-635
-
in contrast to camptothecin, baicalein and luteolin fail to inhibit the religation step when the drugs are added to pre-formed enzyme substrate binary complex. This differential mechanism to induce the stabilization of cleavable complex with topoisomerase I and DNA by these selected flavones and camptothecin result in investigations of the effect of baicalein and luteolin on camptothecin-resistant mutant enzyme LdTOP1D39LS lacking 139 amino acids of the large subunit
G185R
-
substantial level of resistance to camptothecin, 50% inhibition at 0.035 mM
G185R/D325
-
parasites containing both mutations simultaneously show high level of resistance to camptothecin
G185R/D325E
-
highly camptothecin-resistant with two substitutions in the core domain of the protein
H453A
-
Very little relaxing activity detectable, activity of the H453A protein to be more than 100fold reduced compared with that of LdTOPIL-fus-S
H453Q
-
Lower activity than LdTOPIL-fus-S, failing to completely relax the supercoiled DNA even after 40 min
K352A
-
site-directed mutagenesis, the mutant shows highly reduced relaxation activity compared to wild-type enzyme, the cleavage religation equilibrium is shifted towards the cleavage
K352R
-
site-directed mutagenesis, the mutant shows highly reduced relaxation activity compared to wild-type enzyme, the cleavage religation equilibrium is shifted towards the cleavage
R314K
-
site-directed mutagenesis, the mutant shows onyl slightly affected relaxation activity and only a slightly slower rate of cleavage compared to wild-type enzyme
D261A LdTOPIS
-
Site-directed mutagenesis studies identify Lys455 of LdTOPIL and Asp261 of LdTOPIS as two residues involved in subunit interaction. The reconstituted mutant enzymes LdTOPILK436A/S, LdTOPILN441A/S, L/LdTOPISK249A and L/LdTOPISN256A do not show any appreciable change in the relaxation pattern compared with the wild-type enzyme L/S. Reconstitution of L with LdTOPISD261A (SD261A) causes a 15fold decrease in the relaxation activity compared with L/S
GST-LdTOPIS delta 1-201
-
Generated N-and C-terminal-truncated deletion constructs of of L and S subunit. The heterodimerization between the two fragments is weak and therefore co-purified fragments show reduced DNA binding, cleavage and relaxation properties compared with the wild type enzyme
GST-LdTOPIS delta 1-210
-
constitute the minimal interacting fragment. Generated N-and C-terminal-truncated deletion constructs of of L and S subunit. The heterodimerization between the two fragments is weak and therefore co-purified fragments show reduced DNA binding, cleavage and relaxation properties compared with the wild type enzyme
GST-LdTOPIS delta 1-210/delta 255-262
-
Generated N-and C-terminal-truncated deletion constructs of of L and S subunit. The heterodimerization between the two fragments is weak and therefore co-purified fragments show reduced DNA binding, cleavage and relaxation properties compared with the wild type enzyme
GST-LdTOPIS delta 1-215
-
Generated N-and C-terminal-truncated deletion constructs of of L and S subunit. The heterodimerization between the two fragments is weak and therefore co-purified fragments show reduced DNA binding, cleavage and relaxation properties compared with the wild type enzyme
GST-LdTOPIS delta 1-80
-
Generated N-and C-terminal-truncated deletion constructs of of L and S subunit. The heterodimerization between the two fragments is weak and therefore co-purified fragments show reduced DNA binding, cleavage and relaxation properties compared with the wild type enzyme
GST-LdTOPIS delta 245-262
-
Generated N-and C-terminal-truncated deletion constructs of of L and S subunit. The heterodimerization between the two fragments is weak and therefore co-purified fragments show reduced DNA binding, cleavage and relaxation properties compared with the wild type enzyme
GST-LdTOPIS delta 255-262
-
Generated N-and C-terminal-truncated deletion constructs of of L and S subunit. The heterodimerization between the two fragments is weak and therefore co-purified fragments show reduced DNA binding, cleavage and relaxation properties compared with the wild type enzyme
K243A LdTOPIS
-
Site-directed mutagenesis studies identify Lys455 of LdTOPIL and Asp261 of LdTOPIS as two residues involved in subunit interaction. The reconstituted mutant enzymes LdTOPILK436A/S, LdTOPILN441A/S, L/LdTOPISK249A and L/LdTOPISN256A do not show any appreciable change in the relaxation pattern compared with the wild-type enzyme L/S. Reconstitution of L with LdTOPISD261A (SD261A) causes a 15fold decrease in the relaxation activity compared with L/S
K436A LdTOPIL
-
Site-directed mutagenesis studies identify Lys455 of LdTOPIL and Asp261 of LdTOPIS as two residues involved in subunit interaction. The reconstituted mutant enzymes LdTOPILK436A/S, LdTOPILN441A/S, L/LdTOPISK249A and L/LdTOPISN256A do not show any appreciable change in the relaxation pattern compared with the wild-type enzyme L/S. Reconstitution of L with LdTOPISD261A (SD261A) causes a 15fold decrease in the relaxation activity compared with L/S
K455A LdTOPIL
-
Site-directed mutagenesis studies identify Lys455 of LdTOPIL and Asp261 of LdTOPIS as two residues involved in subunit interaction. The reconstituted mutant enzymes LdTOPILK436A/S, LdTOPILN441A/S, L/LdTOPISK249A and L/LdTOPISN256A do not show any appreciable change in the relaxation pattern compared with the wild-type enzyme L/S. Reconstitution of L with LdTOPISD261A (SD261A) causes a 15fold decrease in the relaxation activity compared with L/S
LdTOPIL delta 1-39
-
Generated N-and C-terminal-truncated deletion constructs of of L and S subunit. The heterodimerization between the two fragments is weak and therefore co-purified fragments show reduced DNA binding, cleavage and relaxation properties compared with the wild type enzyme
LdTOPIL delta 1-39/delta457-635
-
constitute the minimal interacting fragment. Generated N-and C-terminal-truncated deletion constructs of of L and S subunit. The heterodimerization between the two fragments is weak and therefore co-purified fragments show reduced DNA binding, cleavage and relaxation properties compared with the wild type enzyme
LdTOPIL delta 1-99
-
Generated N-and C-terminal-truncated deletion constructs of of L and S subunit. The heterodimerization between the two fragments is weak and therefore co-purified fragments show reduced DNA binding, cleavage and relaxation properties compared with the wild type enzyme
LdTOPIL delta 436-635
-
Generated N-and C-terminal-truncated deletion constructs of of L and S subunit. The heterodimerization between the two fragments is weak and therefore co-purified fragments show reduced DNA binding, cleavage and relaxation properties compared with the wild type enzyme
LdTOPIL delta 457-635
-
Generated N-and C-terminal-truncated deletion constructs of of L and S subunit. The heterodimerization between the two fragments is weak and therefore co-purified fragments show reduced DNA binding, cleavage and relaxation properties compared with the wild type enzyme
N256A LdTOPIS
-
Site-directed mutagenesis studies identify Lys455 of LdTOPIL and Asp261 of LdTOPIS as two residues involved in subunit interaction. The reconstituted mutant enzymes LdTOPILK436A/S, LdTOPILN441A/S, L/LdTOPISK249A and L/LdTOPISN256A do not show any appreciable change in the relaxation pattern compared with the wild-type enzyme L/S. Reconstitution of L with LdTOPISD261A (SD261A) causes a 15fold decrease in the relaxation activity compared with L/S
N441A LdTOPIL
-
Site-directed mutagenesis studies identify Lys455 of LdTOPIL and Asp261 of LdTOPIS as two residues involved in subunit interaction. The reconstituted mutant enzymes LdTOPILK436A/S, LdTOPILN441A/S, L/LdTOPISK249A and L/LdTOPISN256A do not show any appreciable change in the relaxation pattern compared with the wild-type enzyme L/S. Reconstitution of L with LdTOPISD261A (SD261A) causes a 15fold decrease in the relaxation activity compared with L/S
E215A
-
mutant activity with the mutation in the Topo-44 fragment (an N-terminal 44-kDa fragment of Topo-V) is active over a wider range of pH values, compared with wild-type enzyme. Mutant activity with the mutation in the Topo-44 fragment (an N-terminal 44-kDa fragment of Topo-V) is active over a wider range of pH values, compared with wild-type enzyme
E215H
-
mutant enzyme is active over a wider range of pH values, compared with wild-type enzyme, mutation in the Topo-44 fragment (an N-terminal 44-kDa fragment of Topo-V)
E215Q
-
mutant enzyme is active over a wider range of pH values, compared with wild-type enzyme, mutation in the Topo-44 fragment (an N-terminal 44-kDa fragment of Topo-V)
E215R
-
mutant enzyme is active over a wider range of pH values, compared with wild-type enzyme, mutation in the Topo-44 fragment (an N-terminal 44-kDa fragment of Topo-V)
H200A
-
mutant enzyme is slightly less active than wild type enzyme, mutation in the Topo-44 fragment (an N-terminal 44-kDa fragment of Topo-V)
H200E
-
mutant has low but detectable DNA relaxation activity at pH 5, mutation in the Topo-44 fragment (an N-terminal 44-kDa fragment of Topo-V)
H200N
-
mutant enzyme is slightly less active than wild type enzyme, mutation in the Topo-44 fragment (an N-terminal 44-kDa fragment of Topo-V)
H200Q
-
mutation in the Topo-44 fragment (an N-terminal 44-kDa fragment of Topo-V)
H200R
-
mutant enzyme shows relaxation activity over a pH range similar to the wild-type enzyme. In the Topo-78 backbone (an N-terminal 78-kDa fragment of Topo-V), qualitatively, H200R is as active as the wild type
K128R
-
mutant enzyme shows very minimal activity at pH 8
K218Q
-
the mutant is inactive in all of the pH conditions tested, mutation in the Topo-78 fragment (an N-terminal 78-kDa fragment of Topo-V)
R131A
-
mutant shows no detectable DNA relaxation activity, mutations in Topo-44 fragment (an N-terminal 44-kDa fragment of Topo-V) or in Topo-78 fragment (an N-terminal 78-kDa fragment of Topo-V)
R131K
-
conservative substitution that retains both the electrostatic and acid/base properties, except for the loss of the bidentate coordination possible through the guanidinium group of the arginine. Whereas the R131K mutant is purified successfully in the Topo-44 backbone, it results in degradation when expressed in the Topo-78 backbone
R144A
-
mutant enzyme shows no activity, mutation in Topo-78 fragment (an N-terminal 78-kDa fragment of Topo-V)
T226F
-
the mutation abolishes activity at all pH values in T44Y226F and shows only minimal activity at pH 8, mutation in the Topo-44 fragment (an N-terminal 44-kDa fragment of Topo-V)
Y226F
-
mutation abolishes DNA binding, mutation in the Topo-44 fragment (an N-terminal 44-kDa fragment of Topo-V)
D111A
site-directed mutagenesis, mutation of the Mg2+-binding residue affects DNA relaxation activity, mutant D111A is dependent on Mg2+ for DNA cleavage and is compromised in religation
D111N
-
site-directed mutagenesis, the mutation is lethal for the host
D113A
site-directed mutagenesis
E115A
site-directed mutagenesis, mutation of the Mg2+-binding residue affects DNA relaxation activity, the mutant is compromised in religation
G116S
-
site-directed mutagenesis, MtTOP1 TOPRIM motif mutation, the mutation inhibits DNA religation. The DNA cleavage activity of MtTOP1-G116 S is Mg2+-dependent
H139C
-
site-directed mutagenesis, the mutant can be labeled with fluorophores with no significant loss of relaxation activity, the mutant complements the temperature sensitive topA function of Escherichia coli strain AS17
K524C
-
site-directed mutagenesis, the mutant can be labeled with fluorophores with no significant loss of relaxation activity, the mutant complements the temperature sensitive topA function of Escherichia coli strain AS17
L170C
-
site-directed mutagenesis, the mutant can be labeled with fluorophores with no significant loss of relaxation activity, the mutant complements the temperature sensitive topA function of Escherichia coli strain AS17
T142C
-
site-directed mutagenesis, the mutant can be labeled with fluorophores with no significant loss of relaxation activity, the mutant complements the temperature sensitive topA function of Escherichia coli strain AS17
Y174C
-
site-directed mutagenesis, the mutant can be labeled with fluorophores with no significant loss of relaxation activity, the mutant complements the temperature sensitive topA function of Escherichia coli strain AS17
D111A
-
site-directed mutagenesis, mutation of the Mg2+-binding residue affects DNA relaxation activity, mutant D111A is dependent on Mg2+ for DNA cleavage and is compromised in religation
-
D113A
-
site-directed mutagenesis
-
E115A
-
site-directed mutagenesis, mutation of the Mg2+-binding residue affects DNA relaxation activity, the mutant is compromised in religation
-
I420V
-
prepared by PCR-based mutagenesis
L530I
-
prepared by PCR-based mutagenesis
N421K
-
prepared by PCR-based mutagenesis
N722S
-
prepared by PCR-based mutagenesis
D710G
-
the mutant is resistant against topotecan
G721D
-
Single amino acid substitutions of yeast Gly721 alters Top1p sensitivity to camptothecin
G721E
-
Single amino acid substitutions of yeast Gly721 alters Top1p sensitivity to camptothecin
G721F
-
Single amino acid substitutions of yeast Gly721 alters Top1p sensitivity to camptothecin
G721L
-
Single amino acid substitutions of yeast Gly721 alters Top1p sensitivity to camptothecin
G721N
-
Single amino acid substitutions of yeast Gly721 alters Top1p sensitivity to camptothecin
G721Q
-
Single amino acid substitutions of yeast Gly721 alters Top1p sensitivity to camptothecin
G721V
-
Single amino acid substitutions of yeast Gly721 alters Top1p sensitivity to camptothecin
L720E
-
Single amino acid substitutions of Leu720 alters Top1p sensitivity to camptothecin
L720Q
-
Single amino acid substitutions of Leu720 alters Top1p sensitivity to camptothecin
N726F
-
specific activity is about 5fold lower than that of wild-type enzyme, self-poisoning phenotype, mutation enhances the kinetics of DNA cleavage
N726H
-
self-poisoning phenotype, specific activity is about 5fold lower than that of wild-type enzyme, binding of DNA increases from 2.5fold at 50 mM KCl to 4fold at 100 mM KCl, 10fold increase in DNA cleavage activity
N726K
-
camptothecin resistance of cells expressing the mutant enzyme
N726Q
-
camptothecin resistance of cells expressing the mutant enzyme
N726S
-
mutant enzyme is resistant to camptothecin
N726Y
-
mutation enhances the kinetics of DNA cleavage
T722A
-
self-poisoning phenotype, reduced rate of DNA religation relative to wild-type enzyme, specific activity of the mutant enzyme is slightly decreased, however protein binding of DNA and rates of enzyme-catalyzed
T722A/N726H
-
specific activity is about 5fold lower than that of wild-type enzyme, N726H mutation potentiates the cytotoxic activity of T722A, increase in DNA cleavage activity
C559A/C561A
no detectable zinc is bound to the mutant enzyme and its fluorescence properties are modified, suggesting a change of conformation in the protein lacking zinc. GThe mutant enzyme exhibits an activity similar to that of the wild-type enzyme with the same optimal temperature for activity. Thermostability is not affected by the mutation. Decatenase activity of wild type and C559A/C561A mutant enzymes shows no significant difference. Cleavage positions obtained with the C559A/C561A mutant is similar to those observed with the wild type enzyme. Preference for cytosine at position -4 is retained, and cleavage intensities are comparable
Y288F
totally inactive protein
C559A/C561A
-
no detectable zinc is bound to the mutant enzyme and its fluorescence properties are modified, suggesting a change of conformation in the protein lacking zinc. GThe mutant enzyme exhibits an activity similar to that of the wild-type enzyme with the same optimal temperature for activity. Thermostability is not affected by the mutation. Decatenase activity of wild type and C559A/C561A mutant enzymes shows no significant difference. Cleavage positions obtained with the C559A/C561A mutant is similar to those observed with the wild type enzyme. Preference for cytosine at position -4 is retained, and cleavage intensities are comparable
-
Y288F
-
totally inactive protein
-
D298A
-
relaxation rate is equivalent to that of the wild-type enzyme in absence and presence of Mg2+
E124A
-
relaxation rate is equivalent to that of the wild-type enzyme in absence and presence of Mg2+
E299A
-
relaxation rate is equivalent to that of the wild-type enzyme in absence and presence of Mg2+
F101A
-
mutant enzyme displayes an aberrant response to magnesium, rate of relaxation is lower by a factor of 4-5 in the presence of 5 mM magnesium than in its absence, the rate of relaxation in presence of NaCl plus magnesium is reduced by a factor of 10.20 compared to wild-type enzyme, affinity for 60-bp duplex is 8fold lower than that of wild-type enzyme
F297A
-
relaxation rate is equivalent to that of the wild-type enzyme in absence and presence of Mg2+
F88A
-
mutant enzyme displayes an aberrant response to magnesium, rate of relaxation is lower by a factor of 4-5 in the presence of 5 mM magnesium than in its absence, the rate of relaxation in presence of NaCl plus magnesium is reduced by a factor of 10-20 compared to wild-type enzyme, affinity for 60-bp duplex is 3fold lower than that of wild-type enzyme
K104A
-
relaxation rate is equivalent to that of the wild-type enzyme in absence and presence of Mg2+
K107A
-
relaxation rate is equivalent to that of the wild-type enzyme in absence and presence of Mg2+
K108A
-
relaxation rate is equivalent to that of the wild-type enzyme in absence and presence of Mg2+
K220A
-
supercoil relaxation by mutant enzyme in presence of NaCl and no divalent cation is slower by a factor of 5 than relaxation by wild-type enzyme, mutant enzyme is inhibited by including Mg2+ with NaCl, rate of relaxation in presence of NaCl plus Mg2+ is reduced by 20fold compared to wild-type enzyme
K220H
-
supercoil relaxation by mutant enzyme in presence of NaCl and no divalent cation is slower by a factor of 5 than relaxation by wild-type enzyme, mutant enzyme is inhibited by including Mg2+ with NaCl, rate of relaxation in presence of NaCl plus Mg2+ is reduced by 40fold compared to wild-type enzyme
K220Q
-
supercoil relaxation by mutant enzyme in presence of NaCl and no divalent cation is slower by a factor of 5 than relaxation by wild-type enzyme, mutant enzyme is inhibited by including Mg2+ with NaCl, rate of relaxation in presence of NaCl plus Mg2+ is reduced by 40fold compared to wild-type enzyme
K220R
-
supercoil relaxation by mutant enzyme in presence of NaCl and no divalent cation is slower by a factor of 2 than relaxation by wild-type enzyme, neither stimulated nor inhibited by Mg2+, rate of relaxation in presence of NaCl plus Mg2+ is reduced by 8fold compared to wild-type enzyme
N103A
-
relaxation rate is equivalent to that of the wild-type enzyme in absence and presence of Mg2+
N228A
-
relaxation of supercoiled DNA in presence of NaCl and no divalent cation is slower by a factor of 8 than relaxation by the wild-type enzyme
N228D
-
relaxation of supercoiled DNA in presence of NaCl and no divalent cation is slower by a factor of 40 than relaxation by the wild-type enzyme, mutant enzyme is inhibited by Mg2+, oligonucleotide cleavage is slower than that of wild-type enzyme by a factor of 200
N228Q
-
relaxation of supercoiled DNA in presence of NaCl and no divalent cation is slower by a factor of 5 than relaxation by the wild-type enzyme, not stimulated by including magnesium with NaCl
N228S
-
relaxation of supercoiled DNA in presence of NaCl and no divalent cation is slower by a factor of 2 than relaxation by the wild-type enzyme
N99A
-
relaxation rate is equivalent to that of the wild-type enzyme in absence and presence of Mg2+
Q116A
-
relaxation rate is equivalent to that of the wild-type enzyme in absence and presence of Mg2+
R90A
-
relaxation rate is equivalent to that of the wild-type enzyme in absence and presence of Mg2+
R97A
-
relaxation rate is equivalent to that of the wild-type enzyme in absence and presence of Mg2+
S204A
-
mutant protein relaxes supercoiled DNA slowly and is strongly inhibited in the presence of salt plus magnesium, the rate of single-turnover religation by covalently bound S204N is indistinguishable from wild-type within the limits of the assay
T296A
-
relaxation rate is equivalent to that of the wild-type enzyme in absence and presence of Mg2+
Y274F
-
vaccinia topoisomerase mutant, lacks active site tyrosine nucleophile but binds to DNA containing specific recognition sequence, like wild type vTopo
A383P
-
mutant enzyme has wild-type levels of relaxation and cleavage activity
C737Y
Q7CIL8
site-directed mutagenesis
D116N/W866L
Q7CIL8
site-directed mutagenesis
D117N
Q7CIL8
site-directed mutagenesis
D117N/C608G
Q7CIL8
site-directed mutagenesis
D117N/C668F
Q7CIL8
site-directed mutagenesis
D117N/C737Y
Q7CIL8
site-directed mutagenesis
D119N
Q7CIL8
site-directed mutagenesis
D80N/G94S/D117N
Q7CIL8
YpTOP39 has D80N, G94S, and D117N mutations
E121Q
Q7CIL8
site-directed mutagenesis
G116S
-
mutant enzyme shows more than 400fold loss of relaxation activity
M326D
-
substitution mutant
M326E
-
substitution mutant
M326K
-
substitution mutant
M326P
-
substitution mutant
M326R
-
overexpression of the M326R mutant YTOP resulted in 4 log loss of viability
M326S
-
substitution mutant
M326T
-
substitution mutant
M326V
-
mutant enzyme has wild-type levels of relaxation and cleavage activity
R327F
-
site-directed mutagenesis, the mutation leads to the SOS response and has a strong cell killing effect when the mutant is overexpressed in Escherichia coli and induced with 0.2% arabinose, the mutant shows reduced DNA cleavage and requirement for Mg2+
R327I
-
site-directed mutagenesis, the mutation leads to the SOS response and has a strong cell killing effect when the mutant is overexpressed in Escherichia coli and induced with 0.2% arabinose, the mutant shows reduced DNA cleavage and requirement for Mg2+
R327L
-
site-directed mutagenesis, the mutation leads to the SOS response and has a strong cell killing effect when the mutant is overexpressed in Escherichia coli and induced with 0.2% arabinose, the mutant shows reduced DNA cleavage and requirement for Mg2+
R327W
-
site-directed mutagenesis, the mutation leads to the SOS response and has a strong cell killing effect when the mutant is overexpressed in Escherichia coli and induced with 0.2% arabinose, the mutant shows reduced DNA cleavage and requirement for Mg2+
T265M
-
site-directed mutagenesis, the mutant does not show a phenotype
V559I
-
site-directed mutagenesis, the mutant does not show a phenotype
D111N
-
EcTOP 67 kDa N-terminal fragment, site-directed mutagenesis
D111N
-
site-directed mutagenesis, the mutant is trapped in complex with DNA, accumulation of the covalent complex of bacterial topoisomerase I is lethal. A full-length enzyme with this D111N mutation could not be expressed, but the N-terminal 67-kDa transesterification domain. Structure comparison of wild-type and D111N mutant enzymes, overview
K532A
cleavage and religation activity of the mutant enzyme are reduced, religation is reduced to a greater extent than cleavage
K532A
expression of the mutant enzyme in Saccharomyces cerevisiae is cytotoxic, this mutant enzyme mimics the effects of the anticancer drug camptothecin
T729K
-
camptothecin resistance, oligonucleotide-directed mutagenesis
T729K
is resistant even at high concentration to camptothecin anti-cancer drug
T729P
-
oligonucleotide-directed mutagenesis
T729P
mild reduction in drug sensitivity and in DNA binding
Y723F
-
site-directed mutagenesis
Y723F
site-directed mutagenesis
Y723F
mutation renders the topoisomerase completely inactive
Y723F
-
catalytically inactive TOP1(Y723F)
Y723F
-
the active site mutant shows abolished formation of Top1 covalent adducts with DNA structures
Y327F
site-directed mutagenesis, the active site mutant construct cannot suppress the slow-growth of top3 mutant Saccharomyces cerevisiae
Y327F
-
site-directed mutagenesis, the active site mutant construct cannot suppress the slow-growth of top3 mutant Saccharomyces cerevisiae
-
N726D
-
mutant enzyme is resistant to camptothecin, no appreciable decrease in catalytic activity, exhibits a distributive mode of plasmid DNA relaxation compared to a progressive mode of the wild-type enzyme. Activity of the mutant enzyme is optimal at 75-100 mM KCl, compared to 150 mM KCl for the wild-type enzyme
N726D
-
self-poisoning phenotype, reduced rate of DNA religation relative to wild-type enzyme, affinity for DNA is reduced about 2.5fold relative to that observed for wild-type Top1p at 50 or 75 mM KCl
Y727F
-
catalytically inactive
Y727F
-
inactive mutant enzyme
Y727F
-
inactive Top1p mutant
Y727F
-
catalytically inactive
-
G122S
Q7CIL8
site-directed mutagenesis
G122S
-
mutant enzyme shows more than 400fold loss of relaxation activity
R327S
-
naturally occuring mutation identified in the AW3-75 mutant, the mutation leads to the SOS response and has a cell killing effect when the mutant is overexpressed in Escherichia coli and induced with 0.2% arabinose
R327S
-
site-directed mutagenesis, the mutant does not show a phenotype
additional information
-
conclude that the active sites of MimiTopIB and vaccinia TopIB are composed of similar functional groups
additional information
An experiment was performed to assess the ability of bcTopo IIIbeta to substitute for ecTopo III in vivo. bcTopo IIIbeta can not substitute for the loss of ecTopo III in Escherichia coli
additional information
-
An experiment was performed to assess the ability of bcTopo IIIbeta to substitute for ecTopo III in vivo. bcTopo IIIbeta can not substitute for the loss of ecTopo III in Escherichia coli
additional information
-
An experiment was performed to assess the ability of bcTopo IIIbeta to substitute for ecTopo III in vivo. bcTopo IIIbeta can not substitute for the loss of ecTopo III in Escherichia coli
-
additional information
comparison of wild-type Escherichia coli topoisomerase III with the Escherichia coli topoisomerase III (Y328F) mutant. Conformational differences: the ssDNA is not as deeply buried in the active site of the open complexes as it is in the topoisomerase IIIY328F+ ssDNA complex. EnzymeDNA interactions along the binding groove in the fully bound wild-type-DNA complex are analogous to those seen in the topoisomerase IIIY328F-DNA structure. Conformation resembles the one observed previously with a DNA-bound, catalytically inactive mutant of topoisomerase III where DNA binding realigns catalytic residues to form a functional active site
additional information
-
comparison of wild-type Escherichia coli topoisomerase III with the Escherichia coli topoisomerase III (Y328F) mutant. Conformational differences: the ssDNA is not as deeply buried in the active site of the open complexes as it is in the topoisomerase IIIY328F+ ssDNA complex. EnzymeDNA interactions along the binding groove in the fully bound wild-type-DNA complex are analogous to those seen in the topoisomerase IIIY328F-DNA structure. Conformation resembles the one observed previously with a DNA-bound, catalytically inactive mutant of topoisomerase III where DNA binding realigns catalytic residues to form a functional active site
additional information
-
expression of His-tagged Yersinia pestis topoisomerase I mutants, that are deficiency in DNA rejoining, under the control of the BAD promoter in plasmid pYTOP in Escherichia coli strain JD5 and purification by nickel affinity chromatography leading to a lethal phenotype of the Escherichia coli cells, overview
additional information
-
dissociation constants obtained for binding of wild-type EcTOP1, R169A, R173A and Y177S mutant enzymes to 3'-labeled 59 base hairpin oligonucleotide substrates, Oligo C, Oligo A and Oligo G, overview
additional information
-
preparation of YrdD protein, the homologue of the topoisomerase I C-terminal region, that contains only iron or zinc by expressing the protein in Escherichia coli cells grown in the M9 minimal media supplemented with either iron or zinc, respectively
additional information
-
usage of isogenic topA+ strain RFM44526 to study the involvement of topoisomerase I function in the SOS response. To monitor the extent of cell killing from accumulation of the topoisomerase I cleavage complex, Escherichia coli strain BW117N with a mutant Yersinia pestis topoisomerase I, YpTOP1-D117N, gene under the control of the BAD promoter inserted into the chromosome36 is used
additional information
-
usage of isogenic topA+ strain RFM44526 to study the involvement of topoisomerase I function in the SOS response. To monitor the extent of cell killing from accumulation of the topoisomerase I cleavage complex, Escherichia coli strain BW117N with a mutant Yersinia pestis topoisomerase I, YpTOP1-D117N, gene under the control of the BAD promoter inserted into the chromosome36 is used
-
additional information
molecular models of human topoisomerase I bearing K532-PL, K532-PLP and K532-PLP-AMP modified residues build with the molecular modelling package Insight II
additional information
-
molecular models of human topoisomerase I bearing K532-PL, K532-PLP and K532-PLP-AMP modified residues build with the molecular modelling package Insight II
additional information
-
Topoisomerase I is modified at the active site by incorporation of a number of tyrosine analogues employed 13 structural analogous of tyrosine. SDS-PAGE, in vitro synthesis of human topoisomerase I analogues modified at position 723. Human topoisomerase I-mediated DNA relaxation assay
additional information
-
p53-/- cell, p53-null variant of HCT116 cells
additional information
plasmid constructs used: pTop65 has an initiator methionine codon followed by Top1 codons 214-765, pTop68 has an initiator methionine codon followed by six histidine codons and four codons encoding the Factor Xa protease-cleavage site, and then Top1 codons 201-765, pTop68W/A is the same as pTop68 except that Trp203, Trp205 and Trp206 are mutated to alanine, pTop69NLS has an initiator methionine codon followed by six histidine codons and four codons encoding the Factor Xa protease-cleavage site, and then Top1 codons 189-765
additional information
-
plasmid constructs used: pTop65 has an initiator methionine codon followed by Top1 codons 214-765, pTop68 has an initiator methionine codon followed by six histidine codons and four codons encoding the Factor Xa protease-cleavage site, and then Top1 codons 201-765, pTop68W/A is the same as pTop68 except that Trp203, Trp205 and Trp206 are mutated to alanine, pTop69NLS has an initiator methionine codon followed by six histidine codons and four codons encoding the Factor Xa protease-cleavage site, and then Top1 codons 189-765
additional information
-
enzyme downregulation by topoisomerase I siRNA in HeLa cells
additional information
-
expression of specific siRNA inhibits the enzyme and elicits distinct changes in TF biosynthesis in TNF-alpha-stimulated endothelial cells, which impact endothelial procoagulant activity
additional information
-
generation of mutant cells that are deficient in mitochondrial isozyme Top1mt, i.e. the Top1mt-/- cell line
additional information
-
in vitro gene fusion of Leishmania bisubunit topoisomerase I into a single ORF encoding a new monomeric topoisomerase I (LdTOPIL-fus-S), N-terminal truncation mutant (1210 amino acids) of the small subunit, when fused to the intact large subunit [LdTOPIL-fus-D(1210)S], shows reduced topoisomerase I activity and camptothecin sensitivity in comparison to LdTOPIL-fus-S experiments in which Leishmania bisubunit topoisomerase I large subunit (LdTOPIL) and small subunit (LdTOPIS) genes are fused into a single ORF encoding a new topoisomerase I (LdTOPIL-fus-S), suicidal cleavage activity and religation activity of LdTOPIL-fus-S and its mutant variants
additional information
-
Leishmania donovani strain Ld160CPTR camptothecin-resistant Leishmania donovani strain. The camptothecin-resistant strain reached a resistance level of 32fold over the wild-type Leishmania donovani AG83 strain. Baicalein and luteolin show inhibition of relaxation activity up to 60% at 30 mM concentration compared with that of camptothecin, where no inhibition of relaxationactivity is observed
additional information
-
three truncated Topo V polypeptides comprising the NH2-terminal 44000 Da and 16000 Da domains, the 44000 Da, 16000 Da and 18000 Da domains and the C-terminal 34000 Da domain. Topo61 and Topo78 are active topoisomerases, but in contrast to Topo V these enzymes are inhibited by high salt concentrations. Topo34 has strong DNA-binding ability but shows no topoisomerase activity. Topo78 and Topi34 possess apurinic/apyrimidinic lyase activity that is important in base excision DNA repair
additional information
preparation of several mutant mTopoI promoters, including wild type and E1, E2, Dbox, E1/Dbox, E1/E2, and E1/E2/Dbox mutant types, and measurement of bioluminescence using a real-time monitoring assay
additional information
-
preparation of several mutant mTopoI promoters, including wild type and E1, E2, Dbox, E1/Dbox, E1/E2, and E1/E2/Dbox mutant types, and measurement of bioluminescence using a real-time monitoring assay
additional information
the His6 tagged-MtbTopA protein is immobilized on an NTA chip. When an increasing amount of GST tagged-Rv2436 protein pass over the chip, they cause a substantial response, overview
additional information
-
the His6 tagged-MtbTopA protein is immobilized on an NTA chip. When an increasing amount of GST tagged-Rv2436 protein pass over the chip, they cause a substantial response, overview
additional information
-
the His6 tagged-MtbTopA protein is immobilized on an NTA chip. When an increasing amount of GST tagged-Rv2436 protein pass over the chip, they cause a substantial response, overview
-
additional information
-
generation of deletion mutants of the enzyme lacking each one of the three basic stretches of the C-terminal domain. The mutants are highly compromised in binding two DNA molecules
additional information
-
TopA depletion in strains PS01 (wild-type background) and PS03 (-parB background). TopA depletion in the -parB background (PS03) leads to a decrease in chromosome segregation abnormalities with 8.9% anucleate prespores compared to that in the parB deletion strain J3305, with 19.5% anucleate prespores
additional information
-
modification of vaccinia topoisomerase I at the active site tyrosine (position 274) with several tyrosine analogues. These analogues have varied steric, electronic, and stereochemical features to permit assessment of those structural elements required to support topoisomerase function. Eleven tyrosine analogues are successfully incorporated into the active site of vaccinia topoisomerase I. It is found that only tyrosine analogues having the phenolic -OH group in the normal position relative to the protein backbone are active. Modifications that replace the nucleophilic tyrosine OH group with NH2, SH, or I groups or that changed the orientation of the nucleophilic OH group essentially eliminate topoisomerase I function